by John Conrad | May 14, 2024 | iBIO News
A new study tackles a burning question: how well do drugs discovered by artificial intelligence fare in clinical trials? With AI making waves in drug discovery, this question is becoming increasingly relevant. The challenge lies in defining what constitutes an...
by John Conrad | Mar 19, 2020 | COVID, COVIDFDA
In response to growing difficulties companies are expecting to face running trials, the Food and Drug Administration has issued a new guidance to help navigate the problems. Considerations for ongoing trials: Ensuring the safety of trial participants is paramount....
by John Conrad | Mar 16, 2020 | COVID, Member News
BIO Business Solutions partner, Scientist.com, has launched a Covid-19 clinical trials tracker and has made it available to everyone at no cost. Scientist.com is an online marketplace for outsourced scientific services and products, offering researchers access to a...
by John Conrad | Feb 18, 2020 | 2019 State Issue
Companion: HB 4314: Medicaid Clinical Trials (Support) iBIO Position: Support Amends the Medical Assistance Article of the Illinois Public Aid Code. Provides that the medical assistance program shall provide coverage for routine care costs that are incurred in the...
